DHQP Global NOFO
Forecast
Centers for Disease Control - NCEZID plans to offer grants to any type of organization. It expects to make about 30 awards worth $60.0 million in total. It is a forecast: the notice is expected around March 21, 2027, with applications due around May 20, 2027.
From the official notice on Grants.gov, last changed August 3, 2026. Checked October 31, 2026.
- Award ceilingnot stated
- Award floornot stated
- Expected awards30
- Total funding$60.0 million
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Forecast posted | August 3, 2026 |
|---|---|
| Expected posting | March 21, 2027 |
| Expected deadline | May 20, 2027 |
| Expected award date | August 31, 2027 |
Add the deadline to your calendar
Who can apply
This opportunity is open to any type of organization.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Open to any type of entity
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The proposed international hybrid Notice of Funding Opportunity (NOFO) will link non-research implementation with targeted research that advances CDC's mission to address antimicrobial resistance (AR) across multiple bacterial and fungal pathogens, healthcare-associated infections (HAIs), and emerging infectious disease threats including viral pathogens across healthcare, community, and environmental settings in low and middle-income countries. AR and HAI remain urgent global threats, with substantial mortality and economic impact. Building on CDC's Global AR Laboratory and Response Network, HAI surveillance and prevention networks, and other collaborating programs, the NOFO seeks to strengthen detection, surveillance, prevention, and response systems to reduce illness and death, stop the spread of AR, protect healthcare workers and patients, and lower costs through robust infection prevention and control (IPC) and antimicrobial stewardship.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Karima Hunter, CK270244@cdc.gov, 000-000-0000.
Questions people ask
Who can apply for DHQP Global NOFO?
Centers for Disease Control - NCEZID accepts applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for DHQP Global NOFO?
Expected deadline May 20, 2027. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
About $60.0 million in total across about 30 awards.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience